A 22-year-old male presents to the emergency department with a 12-hour history of high fever (39.8°C), severe headache, neck stiffness, and photophobia. On examination, he has a petechial rash on his trunk and lower limbs. CSF analysis shows: WBC 850/μL (90% neutrophils), protein 180 mg/dL, glucose 25 mg/dL (serum glucose 95 mg/dL), and Gram stain reveals Gram-negative diplococci. Blood culture is pending. Which of the following is the most appropriate immediate antibiotic therapy?

Explanation

## Diagnosis and Rationale **Key Point:** This patient has acute bacterial meningitis caused by *Neisseria meningitidis*, confirmed by the classic CSF findings (pleocytosis with neutrophil predominance, elevated protein, low glucose-to-serum glucose ratio) and Gram-negative diplococci morphology. ## Treatment Algorithm ```mermaid flowchart TD A[Suspected meningococcal meningitis]:::outcome --> B{Penicillin susceptibility known?}:::decision B -->|No/Empiric therapy| C[Ceftriaxone 2g IV 12-hourly]:::action B -->|Susceptible| D[Penicillin G 4 MU IV 4-hourly]:::action B -->|Resistant/Beta-lactam allergy| E[Chloramphenicol or Fluoroquinolone]:::action C --> F[Add Vancomycin if resistance suspected]:::action D --> G[Clinical improvement + CSF sterilization]:::outcome ``` ## Why Ceftriaxone Is First-Line | Feature | Ceftriaxone | Penicillin G | Chloramphenicol | |---------|-------------|-------------|------------------| | **Spectrum** | Gram-negative cocci + Gram-positive | Gram-positive + Gram-negative cocci | Broad spectrum | | **CNS penetration** | Excellent (even with inflamed meninges) | Good | Moderate | | **Resistance coverage** | Covers penicillin-resistant strains | Does not cover resistant strains | Rarely used now | | **Current guideline** | First-line empiric therapy | Only if susceptibility confirmed | Reserved for allergy | | **Dosing in meningitis** | 2 g IV 12-hourly (higher than other infections) | 4 MU IV 4-hourly | 1 g IV 6-hourly | **High-Yield:** Ceftriaxone is the empiric antibiotic of choice for meningitis in India and globally because it covers both susceptible and moderately resistant *N. meningitidis* strains, achieves excellent CSF penetration, and does not require susceptibility testing to be initiated. **Clinical Pearl:** Although penicillin G remains effective for fully susceptible meningococcal meningitis, resistance patterns have emerged in many regions. Ceftriaxone is preferred empirically because the clinician cannot wait for susceptibility results in a life-threatening condition. **Warning:** Do not use fluoroquinolone monotherapy or chloramphenicol as first-line agents in meningitis — they are reserved for beta-lactam allergy or documented resistance.